CCL20 and breast neoplasm: Gene Expression Profiling Interactive Analysis 2 (GEPIA2) database showed that the expression of CCL20 was positively correlated with the expression of CD11b (a myeloid marker in human, p value = 6.8e-25, R = 0.31) in patients’ breast tumors (Supplementary Fig. S3).